AMLX Amylyx Pharmaceuticals, Inc.

26.20USD-1.58%Mkt Cap: 3.37B USDP/E: —

Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. It provid…